Table 1.
Group | Donor | Treatment | Hearts with Mac-2 ≥2 |
% positive |
Hearts with Mac-2 ≥3 |
% positive |
p value |
---|---|---|---|---|---|---|---|
1 | n/a | C57BL/6 Native Heart | 0/13 | 0 | 0/13 | 0 | |
2 |
BALB/c
H-2d |
Control mIgG2a | 6/14 | 42 | 0/14 | 0 | |
3 |
BALB/c
H-2d |
anti-Kd mIgG2a | 21/25 | 84 | 10/25 | 40 |
0.0002
versus group 2 |
4 |
BALB/c
H-2d |
anti-Dd mIgG2a | 4/5 | 80 | 2/5 | 40 |
0.025
versus group 2 |
5 |
BALB/c
H-2d |
anti-Kd + anti-Dd mIgG2a |
4/4 | 100 | 1/4 | 25 |
0.012
versus group 2 |